Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study. - Filion, Kristian B.; Douros, Antonios; Azoulay, Laurent; Yin, Hui; Yu, Oriana H.; Suissa, Samy (British Journal of Clinical Pharmacology, 2019)